Kousaku Ohinata

This inventor holds 5 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Kyoto University, Kazusa Dna Research Institute, Sunstar Inc.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kousaku Ohinata. Retrieved from https://idiyas.com/inventor/kousaku-ohinata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 16)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

Kazusa Dna Research Institute

The Food Science Institute Foundation

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297240 - Peptide (2025-05-13),

2. 11464824 - Peptide capable of improving cognitive function (2022-10-11),

3. 10676505 - Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof (2020-06-09),

4. 10280202 - Peptide (2019-05-07),

5. 8946164 - Bioactive peptide (2015-02-03),

Title: Kousaku Ohinata: Innovator in Cognitive Function Enhancement

Introduction

Kousaku Ohinata is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of cognitive function enhancement through his innovative peptide inventions. With a total of 5 patents, Ohinata's work focuses on improving cognitive abilities and preventing deterioration in mental function.

Latest Patents

One of his notable inventions is a peptide consisting of specific amino acid sequences, including LSSTOAOOSY, LSSTOAQQSW, and LSSTOAQQSF. This invention aims to provide a new approach to cognitive function improvement. Another significant patent involves a peptide that effectively prevents cognitive decline and enhances cognitive function. This invention utilizes the tripeptide Tyr-Leu-Gly as an active ingredient in various compositions, including food and pharmaceutical products, aimed at promoting brain-derived neurotrophic factor expression in the hippocampus.

Career Highlights

Kousaku Ohinata has worked with esteemed institutions such as Kyoto University and the Kazusa DNA Research Institute. His research and inventions have garnered attention in the scientific community, contributing to advancements in cognitive health.

Collaborations

Ohinata has collaborated with notable colleagues, including Yukiha Mori and Hideyuki Suzuki, further enhancing the impact of his research and inventions.

Conclusion

Kousaku Ohinata's innovative work in peptide development showcases his commitment to enhancing cognitive function. His contributions are paving the way for new solutions in cognitive health and well-being.

Profile summary based on public USPTO records.